全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Toni K. Choueiri , Karen E. Hoffman ...
来源:[J].Brachytherapy(IF 1.22), 2016Elsevier
摘要:Abstract(#br)Purpose(#br)Androgen deprivation therapy (ADT) has been shown to improve survival for men with unfavorable-risk prostate cancer (PCa). We investigated the utilization and factors associated with the omission of ADT in radiation-managed high-risk PCa.(#br)Methods...
作者:Toni K. Choueiri , Christian K. Kollmannsberger ...
来源:[J].Clinical Genitourinary Cancer(IF 1.429), 2014, Vol.12 (5), pp.354-358Elsevier
摘要:Abstract(#br)Introduction/Background(#br)Targeted therapy has become the mainstay of treatment for mRCC. The efficacy of this therapy in the older population is poorly understood.(#br)Patients and Methods(#br)Data from patients with mRCC treated with first-line anti-VEGF the...
作者:... Raphael B. Moreira , Ronit Simantov , Toni K. Choueiri
来源:[J].Clinical Genitourinary Cancer(IF 1.429), 2016Elsevier
摘要:Abstract(#br)Introduction(#br)Observational studies have suggested that metformin use is associated with favorable outcomes in several cancers. For renal cell carcinoma (RCC), data have been limited. Therefore, we investigated the effect of metformin on survival in metastatic RCC...
作者:... Quoc-Dien Trinh , Guru Sonpavde , Toni K. Choueiri
来源:[J].Critical Reviews in Oncology / Hematology(IF 4.637), 2015, Vol.93 (3), pp.257-276Elsevier
摘要:Abstract(#br)A meta-analysis of randomized controlled trials (RCT) was conducted to determine the relative risk (RR) of hepatotoxicity with vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKI). Citations from PubMed/Medline, abstracts from maj...
作者:Toni K. Choueiri , Angela Q. Qu ...
来源:[J].Clinical Genitourinary Cancer(IF 1.429), 2014, Vol.12 (2), pp.130-137Elsevier
摘要:Abstract(#br)Objective(#br)Second-line systemic therapy for advanced urothelial carcinoma (UC) has substantial unmet needs, and current agents show dismal activity. Second-line trials of metastatic UC have used response rate (RR) and median progression-free survival (PFS) as...
作者:Toni K. Choueiri , Aymen A. Elfiky ...
来源:[J].Clinical Genitourinary Cancer(IF 1.429), 2016, Vol.14 (4), pp.e299-e305Elsevier
摘要:Abstract(#br)Introduction(#br)We evaluated the incidence and predictors of the use of long-term (2-3 years) versus shorter term androgen deprivation therapy (ADT) in radiation-managed men with high-risk prostate cancer.(#br)Patients and Methods(#br)We identified 302 patients...
作者:... Daniel T. Ruan , Joaquim Bellmunt , Toni K. Choueiri
来源:[J].Critical Reviews in Oncology / Hematology(IF 4.637), 2014, Vol.92 (2), pp.123-132Elsevier
摘要:Abstract(#br)Adrenocortical cancer is a rare malignancy. While surgery is the cornerstone of the management of localized disease, metastatic disease is hard to treat. Cytotoxic chemotherapy and mitotane have been utilized with a variable degree of benefit and few long-term respon...
作者:Toni K. Choueiri , Pedro Rocha ...
来源:[J].Critical Reviews in Oncology / Hematology(IF 4.637), 2015, Vol.94 (1), pp.136-145Elsevier
摘要:Abstract(#br)A trial-level meta-analysis was conducted to determine the relative risk (RR) of pancreatitis associated with multi-targeted vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKI). Eligible studies included randomized phase 2 and 3 trial...
作者:... Jonathan E. Rosenberg , Joaquim Bellmunt , Toni K. Choueiri
来源:[J].Clinical Genitourinary Cancer(IF 1.429), 2015, Vol.13 (3), pp.250-256Elsevier
摘要:Abstract(#br)Background(#br)Taxanes such as paclitaxel and docetaxel are commonly used for second- or third-line salvage systemic therapy for metastatic UC. Although trials have generally excluded previous exposure to taxanes when using a taxane in a salvage therapy trial, taxane...
作者:Toni K. Choueiri , Jim C. Hu ...
来源:[J].The American Journal of Medicine(IF 4.768), 2015, Vol.128 (6), pp.609-616Elsevier
摘要:Abstract(#br)Purpose(#br)The long-term prostate cancer-specific survival for patients initially managed with active surveillance for low-risk prostate cancer ranges from 97% to 100%. We characterized factors that are associated with aggressive treatment with radical prostate...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×